fluorodeoxyglucose f18 has been researched along with valganciclovir in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alavi, A; Bassetti, M; Carnelutti, A; Di Gregorio, F; Lucchini, E; Muser, D; Pea, F; Righi, E; Zaja, F | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and valganciclovir
Article | Year |
---|---|
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review.
Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Monitoring; Encephalitis, Viral; Fluorodeoxyglucose F18; Ganciclovir; Herpesvirus 6, Human; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Roseolovirus Infections; Treatment Outcome; Valganciclovir | 2017 |